If you've used Rasagiline (Azilect) or Selegline, we want your feedback. Safinamide (brand name Onstryv), which was approved in Europe in February 2015 and in the United States in March 2017, is indicated as an add-on therapy to a regimen that includes levodopa for...
Parkinson Society BC (PSBC) recently conducted a survey with the intent of better understanding the patient’s perspective in achieving symptom control with brand name (Sinemet) vs. generic forms of levodopa. The following is a summary of the 521 responses received:...
We are currently conducting a survey of those affected by Parkinson's disease (PD) in BC. The feedback from this anonymous survey will serve as a guide for us in determining priorities for the future of our programs, services, and advocacy efforts. We appreciate...
As you may know from our recent announcement, Sinemet CR (Controlled Release) is being discontinued by the manufacturer and some dosages of Sinemet IR (Immediate Release or Regular) are in short supply. While it is our understanding that the majority of people are...
With help from members of the Parkinson's community, as part of our 50th anniversary celebration, we have been working on producing a series of videos. These videos are intended to generate awareness of the Society's programs and services, as well as the realities of...
April showers bring May flowers, and with that arrives our annual Spring Auction! If you're looking for a gift for a loved one, or simply interested in treating yourself, we encourage you to check out the items up for bid. Proceeds from this online auction will...
In a statement from Merck Canada Inc., manufacturer of SINEMET®, the following was noted regarding the production of SINEMET® CR (controlled release): "For SINEMET® CR Merck Canada regrets to announce that after having unsuccessfully pursued...
Please be advised that a shortage of Rasagiline has been reported due to a distruption in manufacturing. This shortage was reported on February 20, 2019, with an anticipated end date of May 3, 2019 according to Drug Shortages Canada. As Rasagiline is not covered...
Merck Canada Inc., distributor of SINEMET® (levodopa and carbidopa) in Canada, released a statement on October 30th, 2018 noting that there are global manufacturing delays in the production and resupply of these products. The limited supply, which may result in...
